Silo pharma engages clarivate for intellectual property and patent management

Clarivate will monitor, manage, and maintain company's expanding ip portfolio englewood cliffs, nj, aug. 10, 2023 (globe newswire) --  silo pharma, inc. (nasdaq: silo) (“the company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, announced today that it has retained the services of  clarivate™ , a leading global provider of information services including ip lifecycle management solutions. under terms of the agreement, clarivate will manage, maintain, and track the company's intellectual property assets and technology rights, and serve as an advisor for strategic ip and patent expansion in support of pipeline development.
SILO Ratings Summary
SILO Quant Ranking